The Oxford Parkinson’s Disease Centre (OPDC) is a unique interdisciplinary research centre focussed on understanding the earliest pathological pathways in Parkinson's disease, founded by the £5m Monument Discovery award from Parkinson's UK

Internationally-recognised scientists with strengths in genetics and genomics, transgenic rodent models, in vivo neuroanatomy, neurophysiology and neuropharmacology of the basal ganglia, magnetic resonance imaging (MRI), and analysis of protein biomarkers, work closely with experts in the clinical epidemiology and clinical neurology of Parkinson's disease.

Click here to read the autumn 2011 issue of the OPDC Newsletter.